1. Leukocytoclastic vasculitis following coronavirus disease 2019 (COVID-19): A case report
- Author
-
E. R. Jyothirani, V. T. Sandeep, T. Renuka, and P. M. Shiny
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Dermatology ,Trunk ,Rash ,Complete resolution ,Small vessel vasculitis ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Leukocytoclastic vasculitis ,Parotid enlargement ,Medicine ,Histopathology ,030212 general & internal medicine ,medicine.symptom ,business - Abstract
Leukocytoclastic vasculitis (LCV) refers to the histopathological changes observed in a common form of small vessel vasculitis that can affect skin and/or internal organs. LCV can be precipitated by several causes (including infections, drugs, and collagen vascular diseases) or can be idiopathic. We report a 50-year-old man who presented with fever, parotid enlargement and skin rash (discrete and confluent erythematous macules, papules, and plaques and a few purpuric lesions on the back of trunk and upper limbs), 3 weeks after being diagnosed with coronavirus disease 2019 (COVID-19). The patient showed four out of the five features required to satisfy the working case definition of multisystem inflammatory syndrome in adults (MIS-A). Histopathology of rash was consistent with LCV. Whether, COVID-19 was the cause for LCV in our patient remains unclear. The fever, parotid enlargement and rash showed complete resolution following treatment with systemic corticosteroids and enoxaparin.
- Published
- 2021
- Full Text
- View/download PDF